Logo image of PAVM

PAVMED INC (PAVM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PAVM - US70387R4039 - Common Stock

0.2875 USD
-0.01 (-4.23%)
Last: 12/24/2025, 7:54:18 PM
0.2875 USD
0 (0%)
After Hours: 12/24/2025, 7:54:18 PM
Fundamental Rating

2

Overall PAVM gets a fundamental rating of 2 out of 10. We evaluated PAVM against 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PAVM have multiple concerns. PAVM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PAVM had negative earnings in the past year.
In the past year PAVM has reported a negative cash flow from operations.
PAVM had negative earnings in 4 of the past 5 years.
PAVM had a negative operating cash flow in each of the past 5 years.
PAVM Yearly Net Income VS EBIT VS OCF VS FCFPAVM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

With a decent Return On Assets value of -1.56%, PAVM is doing good in the industry, outperforming 70.81% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.66%, PAVM is in the better half of the industry, outperforming 72.43% of the companies in the same industry.
Industry RankSector Rank
ROA -1.56%
ROE -1.66%
ROIC N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAVM Yearly ROA, ROE, ROICPAVM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PAVM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAVM Yearly Profit, Operating, Gross MarginsPAVM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

2

2. Health

2.1 Basic Checks

PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PAVM has been increased compared to 1 year ago.
Compared to 5 years ago, PAVM has less shares outstanding
PAVM has a better debt/assets ratio than last year.
PAVM Yearly Shares OutstandingPAVM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PAVM Yearly Total Debt VS Total AssetsPAVM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

PAVM has an Altman-Z score of -9.31. This is a bad value and indicates that PAVM is not financially healthy and even has some risk of bankruptcy.
PAVM has a worse Altman-Z score (-9.31) than 81.08% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that PAVM is not too dependend on debt financing.
PAVM has a Debt to Equity ratio of 0.19. This is comparable to the rest of the industry: PAVM outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -9.31
ROIC/WACCN/A
WACC5.81%
PAVM Yearly LT Debt VS Equity VS FCFPAVM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

A Current Ratio of 0.40 indicates that PAVM may have some problems paying its short term obligations.
The Current ratio of PAVM (0.40) is worse than 94.59% of its industry peers.
PAVM has a Quick Ratio of 0.40. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
PAVM has a worse Quick ratio (0.40) than 94.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
PAVM Yearly Current Assets VS Current LiabilitesPAVM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.43% over the past year.
Looking at the last year, PAVM shows a very negative growth in Revenue. The Revenue has decreased by -99.28% in the last year.
The Revenue has been growing by 81.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)90.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.14%
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%

3.2 Future

Based on estimates for the next years, PAVM will show a very strong growth in Earnings Per Share. The EPS will grow by 26.79% on average per year.
The Revenue is expected to grow by 142.05% on average over the next years. This is a very strong growth
EPS Next Y94.12%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PAVM Yearly Revenue VS EstimatesPAVM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
PAVM Yearly EPS VS EstimatesPAVM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PAVM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PAVM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PAVM Price Earnings VS Forward Price EarningsPAVM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVM Per share dataPAVM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PAVM's earnings are expected to grow with 26.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.79%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PAVM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

PAVMED INC

NASDAQ:PAVM (12/24/2025, 7:54:18 PM)

After market: 0.2875 0 (0%)

0.2875

-0.01 (-4.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners9.31%
Inst Owner Change25.32%
Ins Owners8.64%
Ins Owner Change15.5%
Market Cap7.95M
Revenue(TTM)29.00K
Net Income(TTM)-595.00K
Analysts82.5
Price TargetN/A
Short Float %2.61%
Short Ratio0.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-262.66%
Min EPS beat(2)-458.07%
Max EPS beat(2)-67.24%
EPS beat(4)2
Avg EPS beat(4)-4.76%
Min EPS beat(4)-458.07%
Max EPS beat(4)356.41%
EPS beat(8)4
Avg EPS beat(8)-9.4%
EPS beat(12)7
Avg EPS beat(12)-3.45%
EPS beat(16)7
Avg EPS beat(16)-6.47%
Revenue beat(2)0
Avg Revenue beat(2)-60.78%
Min Revenue beat(2)-80.39%
Max Revenue beat(2)-41.18%
Revenue beat(4)0
Avg Revenue beat(4)-60.36%
Min Revenue beat(4)-98.31%
Max Revenue beat(4)-21.57%
Revenue beat(8)0
Avg Revenue beat(8)-35.03%
Revenue beat(12)2
Avg Revenue beat(12)-31.9%
Revenue beat(16)2
Avg Revenue beat(16)-39.94%
PT rev (1m)0%
PT rev (3m)4.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-166.67%
EPS NY rev (3m)-166.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.33%
Revenue NY rev (1m)-39.25%
Revenue NY rev (3m)-39.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 274.02
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS1.29
TBVpS1.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.56%
ROE -1.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.46%
Cap/Sales 72.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z -9.31
F-Score2
WACC5.81%
ROIC/WACCN/A
Cap/Depr(3y)25.15%
Cap/Depr(5y)202.92%
Cap/Sales(3y)138.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.14%
EPS Next Y94.12%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
EBIT growth 1Y63.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.75%
OCF growth 3YN/A
OCF growth 5YN/A

PAVMED INC / PAVM FAQ

What is the fundamental rating for PAVM stock?

ChartMill assigns a fundamental rating of 2 / 10 to PAVM.


Can you provide the valuation status for PAVMED INC?

ChartMill assigns a valuation rating of 1 / 10 to PAVMED INC (PAVM). This can be considered as Overvalued.


Can you provide the profitability details for PAVMED INC?

PAVMED INC (PAVM) has a profitability rating of 1 / 10.


Can you provide the financial health for PAVM stock?

The financial health rating of PAVMED INC (PAVM) is 2 / 10.


Can you provide the dividend sustainability for PAVM stock?

The dividend rating of PAVMED INC (PAVM) is 0 / 10 and the dividend payout ratio is 0%.